Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 22.13%44.83B | 34.94%29.08B | 26.77%13.98B | 20.27%54B | 21.36%36.71B | 14.45%21.55B | 23.07%11.03B | 25.07%44.9B | 15.31%30.25B | 11.25%18.83B |
| Refunds of taxes and levies | 4.24%459.96M | 20.14%330.88M | 63.46%169.5M | -4.34%576.47M | -10.98%441.24M | -21.77%275.42M | -20.61%103.7M | -18.76%602.63M | -0.10%495.66M | 23.29%352.05M |
| Cash received relating to other operating activities | -39.69%494.9M | -68.83%177.41M | -68.76%105.59M | 18.63%855.47M | 54.57%820.62M | 52.13%569.13M | 20.58%338M | 27.38%721.13M | 50.79%530.92M | 45.82%374.11M |
| Cash inflows from operating activities | 20.58%45.79B | 32.13%29.59B | 24.29%14.25B | 19.92%55.43B | 21.41%37.97B | 14.52%22.4B | 22.39%11.47B | 24.23%46.22B | 15.49%31.28B | 11.95%19.56B |
| Goods services cash paid | 18.86%38.73B | 37.94%25.48B | 24.46%12.28B | 22.02%47.52B | 30.99%32.59B | 16.23%18.47B | 21.03%9.87B | 29.85%38.95B | 14.47%24.88B | 12.80%15.89B |
| Staff behalf paid | 19.96%2.67B | 19.58%1.88B | 20.41%1.11B | 23.46%3.05B | 30.28%2.22B | 42.43%1.57B | 74.87%924.31M | 24.55%2.47B | 14.88%1.71B | 5.11%1.1B |
| All taxes paid | 73.54%912.77M | 59.63%629.99M | 36.60%274.26M | -18.84%799.56M | -28.23%525.98M | -23.01%394.66M | -11.20%200.78M | 27.82%985.12M | 20.13%732.85M | 23.04%512.64M |
| Cash paid relating to other operating activities | -1.15%1.16B | 6.13%599.38M | 55.89%341.95M | -14.21%1.21B | 40.65%1.17B | 13.30%564.73M | 2.85%219.35M | 37.58%1.41B | 26.55%831.54M | 0.98%498.45M |
| Cash outflows from operating activities | 19.07%43.47B | 36.12%28.59B | 24.96%14.01B | 20.01%52.58B | 29.69%36.5B | 16.64%21B | 22.92%11.21B | 29.73%43.81B | 14.96%28.15B | 12.20%18.01B |
| Net cash flows from operating activities | 58.21%2.32B | -28.06%1B | -5.16%240.77M | 18.24%2.85B | -53.11%1.47B | -10.10%1.39B | 2.60%253.88M | -29.88%2.41B | 20.46%3.13B | 9.16%1.55B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 362.40%132.84M | 1,075.73%114.15M | --40M | 756.57%39.73M | --28.73M | --9.71M | ---- | -4.46%4.64M | ---- | ---- |
| Cash received from returns on investments | 210.88%51.87M | -23.53%10.72M | --7.05M | -37.65%19.58M | -43.52%16.69M | -52.25%14.02M | ---- | 40.84%31.4M | 536.34%29.54M | 2,902.46%29.35M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 95.24%11.36M | 86.14%9.5M | 317.84%8.47M | 356.11%13.14M | 112.52%5.82M | 133.48%5.11M | -59.85%2.03M | -99.31%2.88M | -98.30%2.74M | -92.56%2.19M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --27.23M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --158.85K | ---- | ---- |
| Cash inflows from investing activities | 282.71%196.08M | 366.07%134.37M | 2,638.67%55.52M | 155.09%99.68M | 58.72%51.24M | -8.59%28.83M | -93.89%2.03M | -91.16%39.08M | -81.05%32.28M | -10.48%31.54M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -5.58%1.62B | -3.11%1.12B | -15.06%566.78M | -44.87%2.38B | -54.47%1.72B | -56.21%1.15B | -58.54%667.31M | -38.95%4.32B | -28.96%3.77B | -24.68%2.63B |
| Cash paid to acquire investments | --170.3M | --170.29M | --60M | -90.06%11M | ---- | ---- | ---- | 440.06%110.68M | --114.65M | --20M |
| Cash paid relating to other investing activities | -99.46%56.9K | -97.87%223.83K | ---- | -76.12%10.51M | -66.25%10.51M | -71.33%10.51M | -47.46%10.51M | -74.71%44M | -82.68%31.14M | -70.44%36.65M |
| Cash outflows from investing activities | 3.71%1.79B | 10.68%1.29B | -7.53%626.78M | -46.29%2.41B | -55.89%1.73B | -56.74%1.16B | -58.40%677.82M | -38.46%4.48B | -28.63%3.91B | -25.70%2.69B |
| Net cash flows from investing activities | 4.82%-1.59B | -1.64%-1.15B | 15.47%-571.26M | 48.06%-2.31B | 56.85%-1.68B | 57.31%-1.13B | 57.66%-675.79M | 35.05%-4.44B | 26.95%-3.88B | 25.85%-2.66B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 3,454.02%562.54M | 840.94%148.93M | 2,186.19%148.6M | 314.35%518.34M | -81.04%15.83M | 190.74%15.83M | 352.58%6.5M | -73.73%125.1M | -89.45%83.5M | -98.35%5.44M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 3,454.02%562.54M | 840.94%148.93M | 2,186.19%148.6M | 1,001.99%518.34M | 190.74%15.83M | 190.74%15.83M | --6.5M | 184.50%47.04M | -98.36%5.44M | -98.35%5.44M |
| Cash from borrowing | 61.73%21.08B | 57.74%13.99B | 71.08%8.58B | -15.96%17.17B | -21.81%13.04B | -32.73%8.87B | -45.13%5.02B | 55.22%20.43B | 79.11%16.67B | 77.29%13.18B |
| Cash received relating to other financing activities | -99.79%992.02K | -99.90%177.06K | ---- | -95.43%10M | 167.15%472.04M | 40.79%179.89M | 100.00%40M | -68.46%218.74M | -84.47%176.69M | -82.25%127.77M |
| Cash inflows from financing activities | 60.06%21.65B | 55.98%14.14B | 72.44%8.73B | -14.80%17.7B | -20.13%13.52B | -31.93%9.06B | -44.76%5.06B | 44.95%20.77B | 50.68%16.93B | 56.92%13.32B |
| Borrowing repayment | 81.46%20.36B | 38.60%12.1B | 108.53%6.17B | 9.74%16.14B | 0.36%11.22B | 11.92%8.73B | -20.31%2.96B | 63.81%14.7B | 67.78%11.18B | 111.17%7.8B |
| Dividend interest payment | 7.40%1.07B | 71.69%886.36M | -8.59%224.74M | -36.00%1.16B | -23.06%997.66M | -51.53%516.26M | 13.81%245.85M | 31.29%1.82B | 9.04%1.3B | 9.14%1.07B |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 237.30%15.63M | ---- | ---- | ---- | --4.63M | ---- | ---- |
| Cash payments relating to other financing activities | -79.81%101.96M | 1,383.68%94.78M | -82.57%7.32M | -77.03%637.47M | -80.55%504.95M | -99.75%6.39M | -98.13%42M | 285.12%2.78B | 1,197.83%2.6B | 1,196.83%2.59B |
| Cash outflows from financing activities | 69.25%21.54B | 41.37%13.08B | 97.19%6.4B | -7.04%17.94B | -15.58%12.72B | -19.25%9.25B | -47.43%3.25B | 74.14%19.29B | 87.17%15.07B | 135.30%11.46B |
| Net cash flows from financing activities | -86.09%111.32M | 653.77%1.05B | 28.30%2.33B | -116.27%-240.1M | -56.98%800.28M | -110.27%-190.5M | -39.25%1.82B | -54.59%1.48B | -41.59%1.86B | -48.68%1.86B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -73.97%-10.36M | 984.07%11.77M | 50.45%-13.78M | -63.37%-45.7M | -478.86%-5.96M | -111.01%-1.33M | -148.45%-27.82M | -133.21%-27.98M | -96.61%1.57M | -23.46%12.09M |
| Net increase in cash and cash equivalents | 41.17%826.74M | 1,240.90%917.14M | 45.29%1.99B | 143.40%253.94M | -47.10%585.64M | -91.03%68.4M | -16.21%1.37B | -746.10%-585.1M | 115.69%1.11B | -48.13%762.61M |
| Add:Begin period cash and cash equivalents | 7.88%3.48B | 7.88%3.48B | 7.88%3.48B | -15.37%3.22B | -15.37%3.22B | -15.37%3.22B | -15.37%3.22B | -1.78%3.81B | -1.78%3.81B | -1.78%3.81B |
| End period cash equivalent | 13.00%4.3B | 33.51%4.39B | 19.04%5.47B | 7.88%3.48B | -22.51%3.81B | -27.99%3.29B | -15.62%4.59B | -15.37%3.22B | 11.95%4.91B | -14.53%4.57B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.